Clarithromycin-containing triple therapy for
Helicobacter pylori
eradication is inducing increased long-term resistant bacteria communities in the gut
Gut
.
2023 Jun 26:gutjnl-2023-329792.
doi: 10.1136/gutjnl-2023-329792.
Online ahead of print.
Authors
Olga Sjomina
1
2
,
Reinis Vangravs
1
,
Elīna Ļeonova
1
2
,
Inese Poļaka
1
,
Dārta Pūpola
1
,
Kristaps Čivkulis
1
,
Aleksandra Jeniceka
2
,
Sergejs Paršutins
1
,
Ilmārs Stonāns
1
,
Jin Young Park
3
,
Lars Engstrand
4
,
Mārcis Leja
5
2
Affiliations
1
Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
2
Faculty of Medicine, University of Latvia, Riga, Latvia.
3
International Agency for Research on Cancer, Lyon, France.
4
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
5
Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia marcis.leja@lu.lv.
PMID:
37364984
DOI:
10.1136/gutjnl-2023-329792
No abstract available
Keywords:
ANTIBIOTICS; COLONIC MICROFLORA; DRUG RESISTANCE; HELICOBACTER PYLORI.
Publication types
Letter
Grants and funding
001/WHO_/World Health Organization/International